Urinary glycosaminoglycans in horse osteoarthritis. Effects of chondroitin sulfate and glucosamine

Research in Veterinary Science

Volumn 93, Issue 1, 2012, Pages 88-96

  Baccarin, Raquel Y A ^b   Machado, Thaís S L ^b   Lopes Moraes, Ana P ^b   Vieira, Fabiana A C ^a   Michelacci, Yara M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chondroitin sulfate; Glucosamine; Horse; Keratan sulfate; Osteoarthritis; Urinary glycosaminoglycan

Indexed keywords

CHONDROITIN SULFATE; CREATININE; GLUCOSAMINE; GLYCOSAMINOGLYCAN; KERATAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ARTHRALGIA; ARTICLE; CARTILAGE MATRIX; CONTROLLED STUDY; CREATININE URINE LEVEL; HORSE; JOINT; JOINT FLEXION; JOINT FUNCTION; JOINT RADIOGRAPHY; JOINT VOLUME; METACARPOPHALANGEAL JOINT; NONHUMAN; OSTEOARTHRITIS; TARSOCRURAL JOINT; TREATMENT RESPONSE; URINARY EXCRETION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHONDROITIN SULFATES; DRUG THERAPY, COMBINATION; GLUCOSAMINE; GLYCOSAMINOGLYCANS; HORSE DISEASES; HORSES; OSTEOARTHRITIS;

EQUIDAE;

EID: 84861483157     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.08.009     Document Type: Article

References (42)

1. Adebowale A., Du J., Liang Z., Leslie J.L., Eddington N.D. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharmaceutics & Drug Disposition 2002, 23:217-225.
2. Aguiar J.A.K., Lima C.R., Berto A.G.A., Michelacci Y.M. An improved methodology to produce Flavobacterium heparinum chondroitinases, important instruments for diagnosis of diseases. Biotechnology and Applied Biochemistry 2003, 37:115-127.
3. Alves M.J.M., Straus A.H., Takahashi H.K., Michelacci Y.M. Production and characterization of monoclonal antibodies to shark cartilage proteoglycan. Brazilian Journal of Medical and Biological Research 1994, 27:2103-2108.
4. Cadaval R.A.M., Kohlmann O., Michelacci Y.M. Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus. Glycobiology 2000, 10:185-192.
5. Campo G.M., Avenoso A., Campo S., D'Ascola A., Traina P., Samà D., Calatroni A. Purified human plasma glycosaminoglycans reduced NF-kappa B activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes. Innate Immun. 2008, 14:233-246.
6. Campo G.M., Avenoso A., Campo S., D'Ascola A., Traina P., Samà D., Calatroni A. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. Journal of Cellular Biochemistry 2009, 106:83-92.
7. Chan P.S., Caron J.P., Orth M.W. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions. American Journal of Veterinary Research 2007, 68:709-715.
8. de Lima C.R., Aguiar J.A.K., Michelacci Y.M. Reduced urinary excretion of sulfated polysaccharides in diabetic rats. Biochimica et Biophysica Acta 2005, 1741:30-41.
9. de Lima C.R., Baccarin R.Y., Michelacci Y.M. Reliability of 1, 9-dimethylmethylene blue tests in comparison to agarose gel electrophoresis for quantification of urinary glycosaminoglycans. Clinica Chimica Acta 2007, 378:206-215.
10. Dechant J.E., Baxter G.M., Frisbie D.D., Trotter G.W., McIlwraith C.W. Effects of glucosamine hydrochloride and chondroitin sulfate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism. Equine Veterinary Journal 2005, 37:227-231.
11. Dietrich C.P., Nader H.B. Fractionation and properties of four heparitin sulfates from beef lung tissue. Isolation and partial characterization of a homogeneous species of heparitin sulfate. Biochimica et Biophysica Acta 1974, 343:34-44.
12. Dietrich C.P., McDuffie N., Sampaio L.O. Identification of acidic mucopolysaccharides by agarose gel electrophoresis. Journal of Chromatography 1977, 130:299-304.
13. Dingle J.T. The effect of nonsteroidal anti-inflammatory drugs on human articular cartilage glycosaminoglycan synthesis. Osteoarthritis and Cartilage 1999, 7:313-314.
14. du Souich P., García A.G., Vergés J., Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. Journal of Cellular and Molecular Medicine 2009, 13:1451-1463.
15. Forsyth R.K., Brigden C.V., Northrop A.J. Double blind investigation of the effects of oral supplementation of combined glucosamine hydrochloride (GHCL) and chondroitin sulphate (CS) on stride characteristics of veteran horses. Equine Veterinary Journal 2006, 36:622-625.
16. Giusti E.P., Sampaio C.A.M., Michelacci Y.M., Stella R.C.R., Oliveira L., Prado E.S. Horse urinary kallikrein. I. Complete purification and characterization. Biological Chemistry 1988, 369:387-396.
17. Iovu M., Dumais G., du Souich P. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis and Cartilage 2008, 16(Suppl. 3):S14-S18.
18. Katta J., Jin Z., Ingham E., Fisher J. Chondroitin sulphate: an effective joint lubricant? Osteoarthr. Cartilage 2009, 17:1001-1008.
19. Largo R., Martínez-Calatrava M.J., Sánchez-Pernaute O., Marcos M.E., Moreno-Rubio J., Aparicio C., Egido J., Herrero-Beaumont G. Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis. American Journal of Physiology. Heart and Circulatory Physiology 2009, 297:H268-H276.
20. Lippiello L., Woodward J., Karpman R., Hammad A. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clinical Orthopaedics and Related Research 2000, 381:229-240.
21. Ma L., Rudert W.A., Harnaha J., Wright M., Machen J., Lakomy R., Qian S., Lu L., Robbins P.D., Trucco M., Giannoukakis N. Immunosuppressive effects of glucosamine. Journal of Biological Chemistry 2002, 277:39343-39349.
22. McIlwraith C.W. Diseases of joint, tendons, ligaments, and related structures. Adams' Lameness in Horses, fifth ed 2002, 494-516. Lippincott Williams & Wilkins, Philadelphia, USA, and 533-539. T.S. Stashak (Ed.).
23. Michelacci Y.M., Mourão P.A.S., Laredo-Filho J., Dietrich C.P. Chondroitin sulfates and proteoglycans from normal and arthrosic human cartilages. Connective Tissue Research 1979, 7:29-36.
24. Michelacci Y.M., Laredo-Filho J., Dietrich C.P. Proteoglycans and chondroitin sulfates from human multiple chondroma (enchondromatosis). Brazilian Journal of Medical and Biological Research 1981, 14:161-172.
25. Michelacci Y.M., Glashan R.Q., Schor N. Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Kidney International 1989, 36:1022-1028.
26. Michelacci Y.M., Boim M.A., Bergamaschi C.T., Rovigatti R.M., Schor N. Possible role for chondroitin sulfate in urolithiasis: In vivo studies in an experimental model. Clinica Chimica Acta 1992, 208:1-8.
27. Mourão P.A.S., Michelacci Y.M., Toledo O.M.S. Glycosaminoglycans and proteoglycans of normal and tumoral cartilages of humans and rats. Cancer Research 1979, 39:2802-2806.
28. Murray R.C., Zhu C.F., Goodship A.E., Lakhani K.H., Agrawal C.M., Athanasiou K.A. Exercise affects the mechanical properties and histological appearance of equine articular cartilage. Journal of Orthopaedic Research 1999, 17:725-731.
29. Murray R.C., Birch H.L., Lakhani K., Goodship A.E. Biochemical composition of equine carpal articular cartilage is influenced by short-term exercise in a site-specific manner. Osteoarthritis Cartilage 2001, 9:625-632.
30. Neil K.M., Caron J.P., Orth M.W. The role of glucosamine and chondroitin sulfate in treatment for and prevention of osteoarthritis in animals. Journal of the American Veterinary MedicalAssociation 2005, 226:1079-1088.
31. Neil K.M., Orth M.W., Coussens P.M., Chan P.S., Caron J.P. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta. American Journal of Veterinary Research 2005, 66:1861-1869.
32. Pereira D.A., Aguiar J.A.K., Hagiwara M.K., Michelacci Y.M. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome. Biochimica et Biophysica Acta 2004, 1272:1-11.
33. Petricevich V.L., Michelacci Y.M. Proteoglycans synthesized in vitro by nude and normal mouse peritoneal macrophages. Biochimica et Biophysica Acta 1990, 1053:135-143.
34. Reginster J.Y. The prevalence and burden of arthritis. Rheumatology (Oxford) 2002, 41:3-6.
35. Richardson D.W., Loinaz R. An evidence-based approach to select joint therapies in horses. The Veterinary Clinics of North America. Equine Practice 2007, 23:443-460.
36. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. A Laboratory Manual, second ed., vol. 3 1989.
37. Sandy J.D., Gamett D., Thompson V., Verscharen C. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochemical Journal 1998, 335:59-66.
38. Shikhman A.R., Brinson D.C., Valbracht J., Lotz M.K. Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes. Osteoarthritis and Cartilage 2009, 17:1022-1028.
39. Stashak T.S. Examination for lameness. Adams' Lameness in Horses, fifth ed. 2002, 113-183. Lippincott Williams & Wilkins, Philadelphia, USA. T.S. Stashak (Ed.).
40. Trumble T. The use of nutraceuticals for osteoarthritis in horses. The Veterinary Clinics of North America. Equine Practice 2005, 21:575-597.
41. Uldry M., Ibberson M., Hosokawa M., Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS Letters 2002, 524:199-203.
42. Vieira F.A.C., Baccarin R.Y.A., Aguiar J.A.K., Michelacci Y.M. Urinary excretion of glycosaminoglycans in horses: changes with age, training and osteoarthritis. Journal of Equine Veterinary Science 2005, 25:387-400.